Thanks to ARMI, stand-in organs have a real chance March 31, 2021 I first wrote about substitute skin in 1993. And at the time, it seemed that stand-in organs—at scale—were imminent.
FMS for Low-Volume, High-Mix Shop Provides Stable, Predictable Process April 29, 2021 Through its 40 years of success, though, the name “Advanced” really became a philosophy and objective, woven into every strand of the company’s DNA.
Group14 Technologies Announces U.S. Plant April 19, 2021 Group14 Technologies, a global provider of silicon-carbon composite materials for lithium-ion markets, announced the launch of its first commercial-scale 27,000-square foot U.S. manufacturing factory.
Automation for Everyone February 18, 2021 Automating job shops is accelerating, driven by the combined influence of Industry 4.0, the continued shortage of skilled manufacturing labor and the COVID pandemic.
ATI Industrial Automation Announces New Robotic Tool Changer March 2, 2021 ATI Industrial Automation’s QC-7 Robotic Tool Changer is a solution for automatic end-effector exchange.
Assisting Small and Medium-Sized Manufacturers with Industry 4.0/Smart Manufacturing Technology Adoption May 14, 2021 Assisting Small and Medium-Sized Manufacturers with Industry 4.0/Smart Manufacturing Technology Adoption
ABB’s IRB 1300 robot enhanced for harsh and cleanroom applications April 29, 2021 IRB 1300 features IP67, Foundry Plus 2 and cleanroom ISO 4 versions, enabling new applications in harsh and contamination-free production environments.
Siemens acquires TimeSeries April 28, 2021 Siemens acquisition of TimeSeries to expand Xcelerator portfolio through development of industry-specific apps built on Mendix platform, help customers speed digital transformation through increased adoption of low-code
The Connected Machine Shop August 24, 2020 Part 1 of this three-part series on the Connected Machine Shop ran in the July issue of Manufacturing Engineering.
In the thick of the ‘herculean’ vaccine push September 21, 2020 In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.